Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 6, 2012, Pages 1344-1354

  Gittler, Julia K ^a,b   Shemer, Avner ^c   Suárez Fariñas, Mayte ^b   Fuentes Duculan, Judilyn ^b   Gulewicz, Kara J ^d   Wang, Claire Q F ^b   Mitsui, Hiroshi ^b   Cardinale, Irma ^b   De Guzman Strong, Cristina ^d   Krueger, James G ^b   Guttman Yassky, Emma ^b,e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d WASHINGTON UNIVERSITY   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

acute; Atopic dermatitis; chronic; IL 22; S100A7; S100A8; S100A9; T H17; TH2; TH22; terminal differentiation

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 31; INTERLEUKIN 4; PSORIASIN; TRANSCRIPTOME;

ACUTE ATOPIC DERMATITIS; ACUTE DISEASE; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CHRONIC ATOPIC DERMATITIS; CHRONIC DISEASE; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN CONTENT; SKIN BIOPSY; TH1 CELL; TH2 CELL; TH22 CELL; UPREGULATION;

ACUTE DISEASE; ADULT; AGED; CALGRANULIN A; CALGRANULIN B; CHRONIC DISEASE; DERMATITIS, ATOPIC; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKINS; MALE; MIDDLE AGED; S100 PROTEINS; SKIN; TH1-TH2 BALANCE; TH17 CELLS; TH2 CELLS; UP-REGULATION; YOUNG ADULT;

EID: 84870294267     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.07.012     Document Type: Article

References (68)

1. T. Bieber Atopic dermatitis N Engl J Med 358 2008 1483 1494
2. D.Y. Leung, M. Boguniewicz, M.D. Howell, I. Nomura, and Q.A. Hamid New insights into atopic dermatitis J Clin Invest 113 2004 651 657
3. J.M. Spergel, and A.S. Paller Atopic dermatitis and the atopic march J Allergy Clin Immunol 112 suppl 2003 S118 S127
4. E. Guttman-Yassky, K.E. Nograles, and J.G. Krueger Contrasting pathogenesis of atopic dermatitis and psoriasis - part I: clinical and pathologic concepts J Allergy Clin Immunol 127 2011 1110 1118
5. C.N. Palmer, A.D. Irvine, and A. Terron-Kwiatkowski Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat Genet 38 2006 441 446
6. E.B. Brandt, and U. Sivaprasad Th2 cytokines and atopic dermatitis J Clin Cell Immunol 2011 2
7. K.E. Nograles, L.C. Zaba, and A. Shemer IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells J Allergy Clin Immunol 123 2009 1244 1252 e2
8. K. Boniface, F.X. Bernard, M. Garcia, A.L. Gurney, J.C. Lecron, and F. Morel IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes J Immunol 174 2005 3695 3702
9. M.D. Howell, B.E. Kim, and P. Gao Cytokine modulation of atopic dermatitis filaggrin skin expression J Allergy Clin Immunol 124 2009 R7 R12
10. K.E. Nograles, L.C. Zaba, and E. Guttman-Yassky Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways Br J Dermatol 159 2008 1092 1102
11. S. Sehra, Y. Yao, and M.D. Howell IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation J Immunol 184 2010 3186 3190
12. E. Guttman-Yassky, K.E. Nograles, and J.G. Krueger Contrasting pathogenesis of atopic dermatitis and psoriasis - part II: immune cell subsets and therapeutic concepts J Allergy Clin Immunol 127 2011 1420 1432
13. B. Homey, M. Steinhoff, T. Ruzicka, and D.Y. Leung Cytokines and chemokines orchestrate atopic skin inflammation J Allergy Clin Immunol 118 2006 178 189
14. F.O. Nestle, D.H. Kaplan, and J. Barker Psoriasis N Engl J Med 361 2009 496 509
15. D. Wilsmann-Theis, T. Hagemann, J. Jordan, T. Bieber, and N. Novak Facing psoriasis and atopic dermatitis: are there more similarities or more differences? Eur J Dermatol 18 2008 172 180
16. Q. Hamid, M. Boguniewicz, and D.Y. Leung Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis J Clin Invest 94 1994 870 876
17. Q. Hamid, T. Naseer, E.M. Minshall, Y.L. Song, M. Boguniewicz, and D.Y. Leung In vivo expression of IL-12 and IL-13 in atopic dermatitis J Allergy Clin Immunol 98 1996 225 231
18. S. Laberge, O. Ghaffar, M. Boguniewicz, D.M. Center, D.Y. Leung, and Q. Hamid Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis J Allergy Clin Immunol 102 1998 645 650
19. R.A. Taha, D.Y. Leung, O. Ghaffar, M. Boguniewicz, and Q. Hamid In vivo expression of cytokine receptor mRNA in atopic dermatitis J Allergy Clin Immunol 102 1998 245 250
20. R.A. Taha, E.M. Minshall, and D.Y. Leung Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis J Allergy Clin Immunol 105 2000 1002 1007
21. M. Grewe, S. Walther, K. Gyufko, W. Czech, E. Schopf, and J. Krutmann Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients J Invest Dermatol 105 1995 407 410
22. T. Thepen, E.G. Langeveld-Wildschut, and I.C. Bihari Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study J Allergy Clin Immunol 97 1996 828 837
23. M. Grewe, K. Gyufko, E. Schopf, and J. Krutmann Lesional expression of interferon-gamma in atopic eczema Lancet 343 1994 25 26
24. J. Ring, U. Darsow, and H. Behrendt Role of aeroallergens in atopic eczema: proof of concept with the atopy patch test J Am Acad Dermatol 45 suppl 2001 S49 S52
25. E. Guttman-Yassky, M. Suarez-Farinas, and A. Chiricozzi Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis J Allergy Clin Immunol 124 2009 1235 1244 e58
26. M. Suarez-Farinas, K. Li, and J. Fuentes-Duculan Expanding the psoriasis disease profile: Interrogation of the skin and serum of patients with moderate-to-severe psoriasis J Invest Dermatol 2012 [Epub ahed of print]
27. F. Chamian, M.A. Lowes, and S.L. Lin Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris Proc Natl Acad Sci U S A 102 2005 2075 2080
28. M. Suarez-Farinas, M. Pellegrino, K.M. Wittkowski, and M.O. Magnasco Harshlight: a "corrective make-up" program for microarray chips BMC Bioinformatics 6 2005 294
29. M.N. McCall, B.M. Bolstad, and R.A. Irizarry Frozen robust multiarray analysis (fRMA) Biostatistics 11 2010 242 253
30. W.E. Johnson, C. Li, and A. Rabinovic Adjusting batch effects in microarray expression data using empirical Bayes methods Biostatistics 8 2007 118 127
31. G.K. Smyth Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat Appl Genet Mol Biol 3 2004 Article3
32. D. Gutowska-Owsiak, A.L. Schaupp, M. Salimi, S. Taylor, and G.S. Ogg Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes Br J Dermatol 165 2011 492 498
33. S.C. Liang, X.Y. Tan, and D.P. Luxenberg Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides J Exp Med 203 2006 2271 2279
34. F. Cevikbas, and M. Steinhoff IL-33: a novel danger signal system in atopic dermatitis J Invest Dermatol 132 2012 1326 1329
35. L. Chen, O. Martinez, L. Overbergh, C. Mathieu, B.S. Prabhakar, and L.S. Chan Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model Clin Exp Immunol 138 2004 375 387
36. A.S. Haider, M.A. Lowes, and M. Suarez-Farinas Identification of cellular pathways of "type 1," Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis J Immunol 180 2008 1913 1920
37. K. Hirahara, K. Ghoreschi, A. Laurence, X.P. Yang, Y. Kanno, and J.J. O'Shea Signal transduction pathways and transcriptional regulation in Th17 cell differentiation Cytokine Growth Factor Rev 21 2010 425 434
38. T. Hirota, A. Takahashi, and M. Kubo Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population Nat Genet 43 2011 893 896
39. B. Ma, W. Liu, and R.J. Homer Role of CCR5 in the pathogenesis of IL-13-induced inflammation and remodeling J Immunol 176 2006 4968 4978
40. R.M. Onishi, and S.L. Gaffen Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease Immunology 129 2010 311 321
41. N. Zhang, H.F. Pan, and D.Q. Ye Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention Mol Cell Biochem 353 2011 41 46
42. S. Eyerich, K. Eyerich, and D. Pennino Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling J Clin Invest 119 2009 3573 3585
43. L.C. Zaba, J. Fuentes-Duculan, and N.J. Eungdamrong Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis J Allergy Clin Immunol 125 2010 1261 1268 e9
44. E. Guttman-Yassky, M.A. Lowes, and J. Fuentes-Duculan Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis J Immunol 181 2008 7420 7427
45. A. Chiricozzi, E. Guttman-Yassky, and M. Suarez-Farinas Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis J Invest Dermatol 131 2011 677 687
46. M. Suarez-Farinas, M.A. Lowes, L.C. Zaba, and J.G. Krueger Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA) PLoS One 5 2010 e10247
47. C. Cornelissen, Y. Marquardt, and K. Czaja IL-31 regulates differentiation and filaggrin expression in human organotypic skin models J Allergy Clin Immunol 129 2012 426 433 e1-8
48. C. Koga, K. Kabashima, N. Shiraishi, M. Kobayashi, and Y. Tokura Possible pathogenic role of Th17 cells for atopic dermatitis J Invst Dermatol 128 2008 2625 2630
49. J. Harder, S. Dressel, and M. Wittersheim Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury J Invest Dermatol 130 2010 1355 1364
50. S. Benoit, A. Toksoy, and M. Ahlmann Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis Br J Dermatol 155 2006 62 66
51. R. Glaser, U. Meyer-Hoffert, and J. Harder The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption J Invest Dermatol 129 2009 641 649
52. H. Martinsson, M. Yhr, and C. Enerback Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation Exp Dermatol 14 2005 161 168
53. J. Roth, T. Vogl, C. Sorg, and C. Sunderkotter Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules Trends Immunol 24 2003 155 158
54. J. Goyette, and C.L. Geczy Inflammation-associated S100 proteins: new mechanisms that regulate function Amino Acids 41 2011 821 842
55. R.L. Eckert, A.M. Broome, M. Ruse, N. Robinson, D. Ryan, and K. Lee S100 proteins in the epidermis J Invest Dermatol 123 2004 23 33
56. B. Sampson, M.K. Fagerhol, and C. Sunderkotter Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism Lancet 360 2002 1742 1745
57. K. Reginald, K. Westritschnig, and T. Werfel Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients Clin Exp Allergy 41 2011 357 369
58. A. Takaoka, I. Arai, M. Sugimoto, A. Yamaguchi, M. Tanaka, and S. Nakaike Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis Eur J Pharmacol 516 2005 180 181
59. S. Kim, H.J. Kim, H.S. Yang, E. Kim, I.S. Huh, and J.M. Yang IL-31 serum protein and tissue mRNA levels in patients with atopic dermatitis Ann Dermatol 23 2011 468 473
60. A. Abtin, L. Eckhart, R. Glaser, R. Gmeiner, M. Mildner, and E. Tschachler The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes J Invest Dermatol 130 2010 2423 2430
61. B. Bai, K. Yamamoto, H. Sato, H. Sugiura, and T. Tanaka Complex regulation of S100A8 by IL-17, dexamethasone, IL-4 and IL-13 in HaCat cells (human keratinocyte cell line) J Dermatol Sci 47 2007 259 262
62. K. Guilloteau, I. Paris, and N. Pedretti Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1α, and TNF-α recapitulates some features of psoriasis J Immunol 2010 [Epub ahead of print]
63. Z. Hegyi, S. Zwicker, and D. Bureik Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis J Invest Dermatol 132 2012 1416 1424
64. A. Johnston, J.E. Gudjonsson, A. Aphale, A.M. Guzman, S.W. Stoll, and J.T. Elder EGFR and IL-1 signaling synergistically promote keratinocyte antimicrobial defenses in a differentiation-dependent manner J Invest Dermatol 131 2011 329 337
65. T. Nukui, R. Ehama, and M. Sakaguchi S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes J Cell Biochem 104 2008 453 464
66. I. Kryczek, A.T. Bruce, and J.E. Gudjonsson Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis J Immunol 181 2008 4733 4741
67. C.S. Bonder, K.V. Davies, E.K. Hosszu, J.J. Finlay-Jones, and P.H. Hart IFN-gamma downregulates interleukin-4 functional activity on monocytes by multiple mechanisms J Interferon Cytokine Res 22 2002 287 293
68. U. Kalinke, and M. Prinz Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS Immunol Cell Biol 90 2012 505 509